0001145549-22-036327.txt : 20220609 0001145549-22-036327.hdr.sgml : 20220609 20220609122034 ACCESSION NUMBER: 0001145549-22-036327 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220609 DATE AS OF CHANGE: 20220609 EFFECTIVENESS DATE: 20220609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Investment Managers Series Trust II CENTRAL INDEX KEY: 0001587982 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22894 FILM NUMBER: 221005364 BUSINESS ADDRESS: STREET 1: 235 WEST GALENA STREET CITY: MILWAUKEE STATE: WI ZIP: 53212 BUSINESS PHONE: 414-299-2295 MAIL ADDRESS: STREET 1: 235 WEST GALENA STREET CITY: MILWAUKEE STATE: WI ZIP: 53212 0001587982 S000071987 Sunbridge Capital Emerging Markets Fund C000227628 Institutional Class CNRYX C000227629 Investor Class RIMIX 0001587982 S000074985 AXS Astoria Inflation Sensitive ETF C000233574 AXS Astoria Inflation Sensitive ETF PPI N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001587982 XXXXXXXX true false false N-1A S000074985 true S000071987 C000227628 C000227629 INVESTMENT MANAGERS SERIES TRUST II 811-22894 0001587982 549300SU7ER9OFETRU41 235 WEST GALENA STREET MILWAUKEE 532123948 US-WI US 4142992000 UMB FUND SERVICES, INC. 235 WEST GALENA STREET MILWAUKEE 53212 4142992000 TRANSFER AGENT, FUND ACCOUNTANT AND CO-ADMINISTRATOR MUTUAL FUND ADMINISTRATION, LLC 2220 E. ROUTE 66, SUITE 226 GLENDORA 91740 6269144141 CO-ADMINISTRATOR UMB BANK, N.A. 928 GRAND BOULEVARD, 5TH FLOOR KANSAS CITY 64106 8168601142 CUSTODIAN IMST Distributors, LLC Three Canal Plaza Suite 100 Portland 04101 8662516920 DISTRIBUTOR Sunbridge Capital Partners LLC 1200 Brickell Avenue, Suite 620 Miami 33131 8777717721 INVESTMENT ADVISER AXS Investments LLC 181 Westchester Avenue Suite 402 Port Chester 10573 8332972587 INVESTMENT ADVISER Astoria Portfolio Advisors LLC 500 7th Avenue, 9th Floor New York 10018 2123816185 SUB ADVISER BROWN BROTHERS HARRIMAN & CO. 50 POST OFFICE SQUARE BOSTON 02110 6177721818 TRANSFER AGENT, FUND ACCOUNTANT AND CUSTODIAN N N N-1A 47 Y ERIC BANHAZL N/A Y JOHN ZADER N/A N KATHLEEN SHKUDA N/A N LARRY TASHJIAN N/A N TERRANCE P. GALLAGHER N/A Y THOMAS KNIPPER N/A N MARTIN W. DZIURA N/A 309 WOODRIDGE LANE MEDIA 19063 XXXXXX N N N N N N N IMST DISTRIBUTORS, LLC 8-66389 000130745 N/A N N TAIT, WELLER & BAKER LLP 00445 N/A N N N N N N N AXS Astoria Inflation Sensitive ETF S000074985 5493001KW9J3YXBP6156 Y 1 1 0 Exchange-Traded Fund Y N Y N N/A N/A N/A Rule 6c-11 (17 CFR 270.6c-11) N N N N AXS Investments LLC 801-117457 000305714 N/A 2021-12-29 Astoria Portfolio Advisors LLC 801-119078 000288271 N/A N Brown Brothers Harriman & Co. 85-0000 5493006KMX1VFTPYPW14 N N Y INTERCONTINENTAL EXCHANGE, INC. 5493000F4ZO33MV32P92 N Refinitiv 549300561UZND4C7B569 N Y Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) RBC INVESTOR SERVICES TRUST FOR RBC 5493002MUOV04NSPT571 CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Y BROWN BROTHERS HARRIMAN & CO. 5493006KMX1VFTPYPW14 LEI N N Y MUTUAL FUND ADMINISTRATION, LLC N/A Y N UMB FUND SERVICES, INC. 084-05792 SEC File Number Y N Y ABN AMRO CLEARING BANK N.V. N/A N/A N/A NL 428.000000000000 VIRTU ITG LLC 008-44218 000029299 549300S41SMIODVIT266 1061.000000000000 1489.000000000000 ABN AMRO CLEARING BANK N.V. N/A N/A N/A NL 854955.000000000000 VIRTU ITG LLC 008-44218 000029299 549300S41SMIODVIT266 7212235.000000000000 8067190.000000000000 N 26805598.000000000000 0.000000000000 N N N N Sunbridge Capital Emerging Markets Fund S000071987 549300KQCNM9MLD6M411 N 2 0 0 N/A Y N Y N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Y Y N N Sunbridge Capital Partners LLC 801-120375 000312611 N/A N UMB FUND SERVICES, INC. 84-5792 N/A Y N Y INTERCONTINENTAL EXCHANGE, INC. 5493000F4ZO33MV32P92 N N UMB BANK, NATIONAL ASSOCIATION VNOO6EITDJ2YUEBMSZ83 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) CITIBANK, N.A., SAO PAULO N/A BR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) EUROCLEAR BK SA NV N/A XX N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) BNPPSS FRANKFURT N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SCB (HONG KONG) LTD N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC HONG KONG N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CITIBANK MUMBAI N/A IN N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CITIBANK JAKARTA N/A ID N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CITIBANK KOREA INC N/A KR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SCB MALAYSIA BERHAD N/A MY N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) BNPPSS NETHERLANDS N/A NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SCB PHILIPPINES N/A PH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) DBS BANK LTD N/A SG N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC SRI LANKA N/A LK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) SCB (TAIWAN) LTD N/A TW N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC THAILAND N/A TH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC BK (VIETNAM) N/A VN N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N UMB FUND SERVICES, INC. 084-05792 SEC File Number Y N Y UMB FUND SERVICES, INC. 084-05792 SEC File Number Y N MUTUAL FUND ADMINISTRATION, LLC N/A N/A Y N Y BANC OF AMERICA SECURITIES LLC 8-42263 000026091 N/A 310819.000000000000 DAIWA CAPITAL MARKETS AMERICA INC. 8-12242 000001576 M67H5PRC0NQKM73ZAS82 261278.000000000000 UBS SECURITIES LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 186649.000000000000 CREDIT SUISSE SECURITIES (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 105101.000000000000 MACQUARIE CAPITAL (USA) INC. 8-47198 000036368 549300670K07JRB5UQ40 99285.000000000000 ICICI SECURITIES INC. 8-52746 000104285 N/A 83868.000000000000 CITIGROUP GLOBAL MARKETS INC. 8-8177 000007059 6SHGI4ZSSLCXXQSBB395 77608.000000000000 HSBC SECURITIES (USA) INC. 8-41562 000019585 CYYGQCGNHMHPSMRL3R97 70612.000000000000 JEFFERIES LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 67472.000000000000 GOLDMAN SACHS & CO. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 33161.000000000000 1372302.000000000000 KOTAK SECURITIES LIMITED N/A N/A 335800UUZDPJ7XGOFU74 IN 6936162.000000000000 CREDIT SUISSE SECURITIES (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 711659.000000000000 MORGAN STANLEY 8-68191 000149777 9R7GPTSO7KV3UQJZQ078 31800.000000000000 7679621.000000000000 Y 549410911.000000000000 0.000000000000 N N N N AXS Astoria Inflation Sensitive ETF S000074985 N 25000.000000000000 0.510000000000 0.150000000000 99.490000000000 0.150000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 350.000000000000 0.000000000000 0.000000000000 350.000000000000 0.000000000000 0.000000000000 350.000000000000 0.000000000000 0.000000000000 350.000000000000 0.000000000000 0.000000000000 Y true INTERNAL CONTROL RPT 2 axsastoriancen.txt INTERNAL CONTROL REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Trustees of Investment Managers Series Trust II Milwaukee, Wisconsin 53212 In planning and performing our audit of the financial statements of AXS Astoria Inflation Sensitive ETF (the Fund), a series of Investment Managers Series Trust II, as of and for the period ended March 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered their internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a companys assets that could have a material effect on the financial statements. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the companys annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of March 31, 2022. This report is intended solely for the information and use of management, Shareholders and Board of Trustees of Investment Managers Series Trust II and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties. /s/TAIT, WELLER & BAKER LLP Philadelphia, Pennsylvania May 27, 2022 To the Shareholders and Board of Trustees of Investment Managers Series Trust II Page Two INTERNAL CONTROL RPT 3 sunbridgecapitalncen.txt INTERNAL CONTROL REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Trustees of Investment Managers Series Trust II Milwaukee, Wisconsin 53212 In planning and performing our audit of the financial statements of Sunbridge Capital Emerging Markets Fund (the Fund), a series of Investment Managers Series Trust II, as of and for the period ended March 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered their internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a companys assets that could have a material effect on the financial statements. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the companys annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of March 31, 2022. This report is intended solely for the information and use of management, Shareholders and Board of Trustees of Investment Managers Series Trust II and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties. /s/TAIT, WELLER & BAKER LLP Philadelphia, Pennsylvania May 27, 2022 To the Shareholders and Board of Trustees of Investment Managers Series Trust II Page Two